Concepedia

Lekha Mikkilineni

LM

18

Publications

1.7K

Citations

14

H-Index

2017

Active since

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

National Institutes of Health

Stanford University

The University of Texas MD Anderson Cancer Center

Lekha Mikkilineni is an author at National Cancer Institute specializing in medicine, immunotherapy, and immunology.

Top concepts

Publications per year

2017–2025

18

Publications

18

T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

Jennifer N. Brudno, Irina Marić, Steven D. Hartman et al. · Journal of Clinical Oncology · 2018 · 778 citations · Full text

Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

Jennifer N. Brudno, Norris Lam, Danielle Vanasse et al. · Nature Medicine · 2020 · 301 citations · Full text

, , +8

A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1–3 inhibitor, cediranib, in recurrent women’s cancers with biomarker analyses

Alexandra S. Zimmer, E. Hitt Nichols, Ashley Cimino‐Mathews et al. · Journal for ImmunoTherapy of Cancer · 2019 · 109 citations · Full text

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

Surbhi Sidana, Krina K. Patel, Lauren C. Peres et al. · Blood · 2024 · 92 citations · Full text

MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer

Jennifer M. Johnson, Paolo Cotzia, Roberto Fratamico et al. · Frontiers in Cell and Developmental Biology · 2017 · 67 citations · Full text

Rows per page

1–5 of 18